FDA 510(k)
FDA class 2
Substantially Equivalent
🇺🇸 United States
BARD AND BTA TEST
K Number: K964151
·
Decision Apr 16, 1997
Classifications
1
FEI Numbers
5
Registration Numbers
5
Same Product Code
8
Applicant Total
3
Review Days
197
Research this 510(k) in seconds
The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.
Free to try · every answer cites its records
Basic Information
- Device Name
- BARD AND BTA TEST
- K Number
- K964151
- Device Class
- FDA class 2
- Clearance Type
- Traditional
- Regulation Number
- 866.6010
- Medical Specialty
- Immunology
- Decision
- Substantially Equivalent
- Statement or Summary
- Summary
- Applicant
- Bard Diagnostic Sciences,Inc.
- Date Received
- October 1, 1996
- Decision Date
- April 16, 1997
- Product Code
- MMW
- Advisory Committee
- Immunology
- Review Advisory Committee
- IM
- Third Party
- N
Classifications
This FDA 510(k) entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| MMW | System, Test, Tumor Marker, Monitoring, Bladder | FDA class 2 | Immunology |
Similar 510(k) Clearances
Other 510(k) clearances with the same product code (MMW), ordered by most recent decision date.
Bladder EpiCheck DNA extraction kit, NX899090-01C, Bladder EpiCheck test kit, NX899090-02C, Bladder EpiCheck Software, NX899090-03C
FDA 510(k)
FDA Class 2
·Immunology
MODIFICATION TO VYSIS UROVYSION BLADDER CANCER RECURRENCE TEST
FDA 510(k)
FDA Class 2
·Immunology
NMP22 BLADDERCHEK KIT, NMP22 CONTROL KIT
FDA 510(k)
FDA Class 2
·Immunology
UROVYSION BLADDER CANCER RECURRENCE KIT
FDA 510(k)
FDA Class 2
·Immunology
VYSIS UROVYSION BLADDER CANCER RECURRENCE KIT
FDA 510(k)
FDA Class 2
·Immunology
BTA STAT TEST PRESCRIPTION HOME USE
FDA 510(k)
FDA Class 2
·Immunology